Christian Kollmannsberger
BC Cancer Agency(CA)University of British Columbia(CA)Loma Linda University(US)Spinal Cord Injury BC(CA)BC Cancer Foundation(CA)Canadian Centre for Applied Research in Cancer Control(CA)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Testicular diseases and treatments, Cancer Genomics and Diagnostics, Renal and related cancers, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma(2015)5,839 cited
- → Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma(2018)4,536 cited
- → Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma(2019)2,502 cited
- → Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study(2009)2,104 cited
- → External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study(2013)1,008 cited
- → Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial